Why were we wrong for so long? The pancreas of type 1 diabetic patients commonly functions for decades Denise L. Faustman Commentary 05 November 2013 Pages: 1 - 3
A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications G. P. Fadini Review 31 October 2013 Pages: 4 - 15
The potential of novel biomarkers to improve risk prediction of type 2 diabetes Christian HerderBernd KowallWolfgang Rathmann Review 29 September 2013 Pages: 16 - 29
HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis Soraya SoulimaneDominique SimonDESIR Study Group Meta-analysis 25 September 2013 Pages: 30 - 39
Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study Gerd KoehlerSimon HellerThomas R. Pieber Article Open access 22 September 2013 Pages: 40 - 49
Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes Daniel EspesJoey LauPer-Ola Carlsson Short Communication Open access 27 September 2013 Pages: 50 - 53
Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia Amanda StrideBeverley ShieldsAndrew T. Hattersley Short Communication Open access 04 October 2013 Pages: 54 - 56
Incidence of type 1 diabetes in Norway among children aged 0–14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry Torild SkrivarhaugLars C. SteneNorwegian Childhood Diabetes Study Group Article 23 October 2013 Pages: 57 - 62
Lifestyle factors and mortality risk in individuals with diabetes mellitus: are the associations different from those in individuals without diabetes? Diewertje SluikHeiner BoeingUte Nöthlings Article 17 October 2013 Pages: 63 - 72
Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes Andrew J. M. CooperSoren BrageRebecca K. Simmons Article Open access 03 October 2013 Pages: 73 - 82
Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study Carlos LorenzoAnthony J. HanleySteven M. Haffner Article 19 October 2013 Pages: 83 - 92
Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women Sylvia H. LeyQi SunFrank B. Hu Article 09 October 2013 Pages: 93 - 101
Maternal diabetes in pregnancy and offspring cognitive ability: sibling study with 723,775 men from 579,857 families Abigail FraserCatarina AlmqvistDebbie A. Lawlor Article Open access 25 September 2013 Pages: 102 - 109
Association between maternal folate concentrations during pregnancy and insulin resistance in Indian children Ghattu V. KrishnaveniSargoor R. VeenaCaroline H. D. Fall Article Open access 26 October 2013 Pages: 110 - 121
Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion J. M. LockeG. da Silva XavierL. W. Harries Article Open access 23 October 2013 Pages: 122 - 128
Lysosomal acid lipase and lipophagy are constitutive negative regulators of glucose-stimulated insulin secretion from pancreatic beta cells Gemma L. PearsonNatalie MellettTrevor J. Biden Article 23 October 2013 Pages: 129 - 139
Short-term overexpression of VEGF-A in mouse beta cells indirectly stimulates their proliferation and protects against diabetes Nico De LeuYves HeremansHarry Heimberg Article 12 October 2013 Pages: 140 - 147
Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands Haiya WuKarima MezghennaCarlos F. Ibáñez Article 17 October 2013 Pages: 148 - 156
SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity Masatoshi NomuraHai-Lei ZhuNoriyoshi Teramoto Article 26 September 2013 Pages: 157 - 166
Characterising metabolically healthy obesity in weight-discordant monozygotic twins J. NaukkarinenS. HeinonenK. H. Pietiläinen Article 08 October 2013 Pages: 167 - 176
Counteracting neuronal nitric oxide synthase proteasomal degradation improves glucose transport in insulin-resistant skeletal muscle from Zucker fa/fa rats Karima MezghennaJérémy LeroyAnne-Dominique Lajoix Article 02 November 2013 Pages: 177 - 186
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells Richard A. OramAngus G. JonesTimothy J. McDonald Article Open access 12 October 2013 Pages: 187 - 191
Retinal proteome alterations in a mouse model of type 2 diabetes Alice LyMarkus F. ScheererMarius Ueffing Article Open access 29 September 2013 Pages: 192 - 203
NRF2 plays a protective role in diabetic retinopathy in mice Zhenhua XuYanhong WeiElia J. Duh Article 03 November 2013 Pages: 204 - 213
Aggravation of diabetic nephropathy in BCL-2 interacting cell death suppressor (BIS)-haploinsufficient mice together with impaired induction of superoxide dismutase (SOD) activity Ji Hee LimDong-Ye YounJeong-Hwa Lee Article 29 September 2013 Pages: 214 - 223
Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes Olaf BrouwersPetra M. G. NiessenCasper G. Schalkwijk Article 26 October 2013 Pages: 224 - 235
Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic pro-opiomelanocortin (POMC) neurons Xiaorui WangZsombor LaczaWeiping Han Article 28 September 2013 Pages: 236 - 245
Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function Raquel Ferrer-LorenteMaria Teresa BejarLina Badimon Article 17 October 2013 Pages: 246 - 256
Nitric oxide vs insulin secretion, action and clearance Olga Kruszelnicka Letter 18 October 2013 Pages: 257 - 258
Risk stratification for diabetic eye screening Irene M. StrattonSteve J. Aldington Letter 22 September 2013 Pages: 259 - 259
Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter] H. C. LookerS. O. Nyangomaon behalf of the Scottish Diabetes Research Network Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative Letter 08 November 2013 Pages: 260 - 261
Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells Richard A. OramAngus G. JonesTimothy J. McDonald Erratum 19 November 2013 Pages: 262 - 262
Erratum to: Differences in metabolic and mitogenic signalling of insulin glargine and AspB10 human insulin in rats N. TennagelsS. WelteU. Werner Erratum 24 October 2013 Pages: 263 - 263
